Composition of IRS 19
100 ml of IRS 19 contains 43.27 ml of a mixture of lysates of the following bacteria: Klebsiella pneumonia, Streptococcus pneumoniae (types 1, 2, 3, 4), Acinetobacter calcoaceticus, Streptococcus pneumoniae (types 2, 3, 5, 8, 12) , Streptococcus pyogenes A-group, Haemophilus influenzae B-type, Staphylococcus aureus, Moraxella catarrhalis, Enterococcus faecalis, Neisseria subflava and perflava, Streptococcus dysgalactiae C-group, Enterococcus faecium, Streptococcus G-group.
Additional substances: sodium merthiolate, glycine, water, nerol-based flavoring.
Pharmacodynamics and pharmacokinetics
An immunostimulating drug based on bacterial lysates. Strengthens specific and nonspecific types of immunity .
When spraying the medicine, an aerosol is formed that envelops the nasal mucosa, which leads to the active development of a local immune response. This protection is due to locally formed antibodies such as secretory immunoglobulins A , which prevent the strengthening and reproduction of pathogens on the surface of the mucosa.
Nonspecific protection manifests itself in increased phagocytic activity of macrophage cells and increased lysozyme content.
Description of the product
IRS19 nasal spray, the instructions confirm this, is an effective immunostimulating drug. It is produced on a bacterial basis using bacterial lysates. These are fragments of harmful microorganisms. They cannot harm the body or cause disease, but the immune system identifies them as a threat, and therefore turns on additional protection on the nasal mucosa. As a result, it is possible to successfully fight a dangerous seasonal infection that can enter the respiratory system through airborne droplets.
The drug contains lysates of 18 bacteria. They are the ones that most often cause the spread of seasonal respiratory infections. If using the drug failed to protect against the disease, then by turning on additional protective reactions, the disease can be dealt with faster. Also in this case, the risks of developing severe influenza or ARVI are reduced.
The solution is a clear, colorless liquid that may have a slightly yellowish tint. The spray is easily recognized by its weak, but specific smell. When using the spray, a fine aerosol covers the entire mucous membrane of the nasal passages, even in hard-to-reach places. This allows you to form a guaranteed immune response.
Indications for use
The use of the drug is due to the following situations:
- prevention of chronic respiratory diseases;
- restoration of the local immune response after viral diseases;
- therapy of acute and chronic respiratory tract diseases ( sinusitis, rhinitis, tracheitis, laryngitis, tonsillitis, pharyngitis, bronchitis );
- preparation for planned surgery on ENT organs and recovery in the postoperative period.
Using the product
IRS19 spray is effective in the prevention and treatment of various diseases of the upper respiratory tract, provoked by infectious infection, occurring in chronic or acute form. The effectiveness of the drug has also been proven after ARVI and influenza, when it is necessary to restore local immunity. You can also buy the spray:
- Preparation for planned operations on ENT organs.
- Necessities of the patient's condition in the postoperative period.
The spray can be used to treat adults and children after 3 months. The drug is used as a one-time injection of one dose, which is obtained by briefly pressing the spray bottle.
IRS19, the instructions for use emphasize this, should be used in accordance with the following recommendations:
- For preventive purposes, use one dose twice a day in each nasal passage. Procedures should be started a couple of weeks before the expected seasonal surge in infectious diseases.
- In combination with other medications during therapy, the above dosage regimen is followed until the age of 3 years. But before the procedure, you must clear your nose of mucous secretions. After reaching 3 years, the number of doses per day can be increased up to 5 times. Treatment with the drug is allowed until the symptoms of the disease completely disappear.
- When using the medicine for the purpose of recovery from illness or in preparation for surgery on the ENT organs, it is necessary to spray 1 dose per day into each nasal passage. The duration of the procedures is a couple of weeks after illness or before the scheduled date of surgery.
Side effects
Side effects may or may not be caused by taking the drug. If any of the following symptoms appear, it is advisable to consult a doctor.
- Dermatological reactions: thrombocytopenic purpura, eczema-like and erythema-like reactions, erythema nodosum.
- Allergic reactions: Quincke's edema , urticaria .
- Respiratory system disorders: laryngitis, nasopharyngitis asthma attacks cough, bronchitis.
- Digestive disorders: vomiting, nausea, diarrhea , abdominal pain.
- Other disorders: hyperthermia for no apparent reason.
Instructions for use IRS 19 (Method and dosage)
The medicine is used intranasally, spraying 1 dose of aerosol by one short press on the top of the spray bottle.
Spray IRS 19, instructions for use
In order to prevent infections for children and adults, it is recommended to take 1 dose of the medicine in each nasal passage twice a day for 2 weeks (it is recommended to start several weeks before the expected epidemic rise).
For the treatment of acute and chronic respiratory tract infections, children 3-36 months of age are prescribed one dose of medication in each nasal passage twice a day after preliminary clearing of mucus and so on until signs of infection disappear. All other age categories of people are prescribed 1 dose in each nasal passage 2-4 times a day until signs of infection disappear.
To restore local immunity after respiratory viral diseases, children and adults are recommended to take 1 dose in each nasal passage twice a day for 2 weeks.
To prepare for planned surgery and during recovery in the postoperative period, children and adults are recommended to take 1 dose in each nostril twice a day for two weeks (it is recommended to start therapy 7 days before surgery).
Rules for using the drug
For the aerosol can to work properly, you need to place the nozzle on top of the can and gently press it. After which the device is ready for use.
When spraying the drug, the bottle must be kept exclusively in a vertical position; the patient should not throw back his head.
When using the medicine continuously, it is not recommended to remove the nozzle from the bottle.
The resulting crystals close the outlet of the bottle if the medicine is left for a long time without use. If such a blockage of the nozzle occurs, then it is necessary to make several presses so that the mouth is cleared under the influence of high pressure; If there is no effect, it is recommended to immerse the nozzle in warm water for a few minutes.
Impact after administration
The medicine begins to act almost immediately after spraying into the nasal cavity. This shows up:
- Increasing the production of your own interferon. This protein has antiviral activity.
- Increased production of lysozyme. This enzyme has bactericidal properties.
- Activation of phagocytosis. The process involves the absorption of foreign microorganisms by cells of the immune system - phagocytes.
- Accelerating the production of secretory immunoglobulin A. This substance provides local protection of the mucous membranes.
Adaptive immunity, which is associated with the production of antibodies within a month, appears 2–4 days after using the spray. This allows complex therapy to speed up the patient’s recovery and reduce the likelihood of complications. Due to the formation of adaptive immunity, IRS19 allows protection against infection for up to 4 months.
special instructions
In the first week of treatment, sneezing and nasal discharge may occur. These phenomena are usually short-lived. If these reactions intensify, the number of injections of the drug should be reduced or discontinued.
Also rarely, at the beginning of treatment, an increase in body temperature above 39°C is possible. In this case, the medicine should be discontinued.
However, it is necessary to carry out a differential diagnosis between this condition and an increase in temperature associated with the development of diseases of the ENT organs.
If clinical signs of a bacterial infection appear, the prescription of antibacterial drugs while the use of IRS 19 continues.
When prescribing the medicine to people with bronchial asthma, an increase in attacks cannot be ruled out. In this case, it is recommended to stop treatment and not use drugs of this type in the future.
Contraindications and negative reactions
An absolute contraindication to the use of the drug is hypersensitivity to its components. This means that you must carefully read the composition of the spray. The drug is not prescribed for diagnosed autoimmune diseases.
The drug has not been tested for its effects on the fetus and newborn child. Therefore, it is recommended not to use the drug during pregnancy and breastfeeding.
At the beginning of treatment, negative reactions of the body are often observed, which are manifested by sneezing and nasal discharge. But such symptoms are temporary and disappear quickly. You can temporarily reduce the dosage. In severe cases, when negative reactions intensify, the drug should be discontinued.
If you are intolerant to the medication, negative skin reactions such as urticaria or eczema are possible. Also, IRS19, reviews confirm this, can provoke coughing and asthma attacks. Sometimes patients noted increased body temperature, abdominal pain, diarrhea, nausea and vomiting. Cases of overdose have not been observed in practice.
IRS19 spray is an over-the-counter drug that has no structural analogues. The medicine should be stored in an upright position, in a place out of direct sunlight and out of reach of children. Shelf life – 3 years. Expired medicine should not be used.
Reviews about IRS 19
Reviews of IRS 19 for children and adults are a rare case when patients are divided into two camps with diametrically opposed views on the drug. Some report the absolute benefits, harmlessness and almost miraculous nature of the drug. Others talk about the extreme danger of its use, the development of severe complications, especially when administered to children.
Reviews from doctors about IRS 19 are more restrained and warn of the need for an integrated approach to the treatment of viral diseases. However, the drug also has fans among doctors, for example, Dr. Komarovsky actively recommends using the drug on his website and reports that in his practice there have been no cases of any serious complications after taking the drug.
In general, there is a fairly large percentage of reviews talking about the identification of allergic reactions that occurred as edema.
Pharmacological properties of the drug Irs 19
IRS 19 is a complex preparation of bacterial lysates, the most common pathogens of respiratory infections. The lysis of microorganisms occurs according to an original biological technique, which makes it possible to obtain non-pathogenic antigens while preserving the specific characteristics of each strain, and at the same time, lysates, when applied to the mucous membranes of the respiratory tract, are capable of causing protective immune reactions identical to those against infectious agents: stimulation and reproduction of immunocompetent cells , increasing the level of lysozyme and interferon in the secretion, increasing the amount of local antibodies, especially immunoglobulin A, increasing phagocytic activity, facilitating the elimination of infectious agents from the body.
Price, where to buy
The price of IRS 19 in Russia is 370-450 rubles. In Ukraine, the price of such a drug is on average 335 hryvnia, and buying a package of the above-described medicine in Belarus will cost 150,000-250,000 Belarusian rubles.
- Online pharmacies in RussiaRussia
ZdravCity
- Irs 19 nasal spray.
60 doses 20ml Mailan Laboratories SAS/JSC Pharmstandard-Tomskkhimpharm 553 RUR order
